Urban Strategies, Inc. (USI) received a $1.5 million grant from Truist Foundation to expand its Community Development Financial Institution (CDFI) small business loan fund to five new cities: Memphis, Fort Worth, Houston, Jacksonville, and Philadelphia. This funding will enhance access to capital, technical assistance, and business resources for entrepreneurs who face barriers to traditional financing, supporting business growth and community wealth building. The grant builds on a previous $1.5 million award in 2023 for work in Norfolk, Baltimore, and Fort Myers. USI aims to empower entrepreneurs not just with loans but also with tools for credit-building and business development, contributing to economic mobility and neighborhood transformation.
Urban Strategies, Inc. grant news offers context for Financials-sector stocks on Pluang. For readers following Financials, 68 of 85 US stocks rose and 17 fell as of Oct 06, 2026 22:12 WIB. Notable movers include FUTU at USD 112.25 (+2.32%), NU at USD 15.50 (+2.11%), and COIN at USD 192.18 (+2.10%).
Neogen reported earnings per share of $0.08 and revenue of $222.8 million, both exceeding analyst expectations. The company also announced a strategic partnership with Hinalea Imaging Corp. to develop digital food safety tools. However, Neogen's stoc...
PepsiCo is set to report its Q3 2026 earnings with expectations of $2.29 EPS and $25 billion revenue. The company faces challenges in North America, where organic revenue declined due to pricing pressures and changing consumer preferences. To adapt, ...
Stryker experienced an 8.8% stock drop on September 8, 2026, wiping out over $10 billion in market value due to ongoing manufacturing problems that were thought resolved. Truist Financial lowered its price target from $340 to $310, reflecting concern...
Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...
Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...
